TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

TriNetX Joins CERTAINTY Project to Enhance Cancer Immunotherapy

Cambridge, MA, January 31, 2024 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, is proud to announce its participation in the CERTAINTY project. CERTAINTY, short for CEllulaR...